Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide
npj Breast Cancer · 12.08.2026
DOI: 10.1038/s41523-026-01034-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift npj Breast Cancer, online erschienen am 12.08.2026. Verfasst von Nay N. N. Chan und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, Breast Cancer Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Cancer Institute
- Breast Cancer Research Foundation
Zitieren
APA
Chan, N. N. N., Benanto, J., Scott, L., He, M., Robbins, C. J., Liebler, D. C., Fulton, R., & Rimm, D. L. (2026). Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide. npj Breast Cancer. https://doi.org/10.1038/s41523-026-01034-8
Vancouver
Chan NNN, Benanto J, Scott L, He M, Robbins CJ, Liebler DC, et al. Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide. npj Breast Cancer. 2026. doi:10.1038/s41523-026-01034-8
BibTeX
@article{Chan2026,
author = {Chan, Nay N. N. and Benanto, Julia and Scott, Liam and He, Mengni and Robbins, C. Jack and Liebler, Daniel C. and Fulton, Regan and Rimm, David L.},
title = {Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide},
journal = {npj Breast Cancer},
year = {2026},
doi = {10.1038/s41523-026-01034-8}
}
EUVIMED